Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1700

1.

NMO spectrum of disorders: A paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases.

Vaknin-Dembinsky A, Karussis D, Avichzer J, Abramsky O.

J Autoimmun. 2014 Aug 13. pii: S0896-8411(14)00093-6. doi: 10.1016/j.jaut.2014.05.004. [Epub ahead of print] Review.

PMID:
25129503
[PubMed - as supplied by publisher]
2.

Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.

Pula JH, Kattah JC, Keung B, Wang H, Daily J.

J Neurol Sci. 2014 Jul 28. pii: S0022-510X(14)00495-X. doi: 10.1016/j.jns.2014.07.049. [Epub ahead of print]

PMID:
25125046
[PubMed - as supplied by publisher]
3.

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Papadopoulos MC, Bennett JL, Verkman AS.

Nat Rev Neurol. 2014 Aug 12. doi: 10.1038/nrneurol.2014.141. [Epub ahead of print]

PMID:
25112508
[PubMed - as supplied by publisher]
4.

Complement activation in patients with neuromyelitis optica.

Nytrova P, Potlukova E, Kemlink D, Woodhall M, Horakova D, Waters P, Havrdova E, Zivorova D, Vincent A, Trendelenburg M.

J Neuroimmunol. 2014 Jul 11. pii: S0165-5728(14)00216-1. doi: 10.1016/j.jneuroim.2014.07.001. [Epub ahead of print]

PMID:
25109258
[PubMed - as supplied by publisher]
5.

Serum thyroid-stimulating hormone and anti-thyroglobulin antibody are independently associated with lesions in spinal cord in central nervous system demyelinating diseases.

Long Y, Zheng Y, Chen M, Zhang B, Gao C, Shan F, Yang N, Fan Y.

PLoS One. 2014 Aug 5;9(8):e100672. doi: 10.1371/journal.pone.0100672. eCollection 2014.

PMID:
25093326
[PubMed - in process]
Free PMC Article
6.

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.

Absoud M, Lim MJ, Appleton R, Jacob A, Kitley J, Leite MI, Pike MG, Vincent A, Wassmer E, Waters P, Woodhall M, Hemingway C, Palace J.

J Neurol Neurosurg Psychiatry. 2014 Aug 4. pii: jnnp-2014-308550. doi: 10.1136/jnnp-2014-308550. [Epub ahead of print]

PMID:
25091363
[PubMed - as supplied by publisher]
7.

The natural course of clinically isolated syndrome in pediatric patients.

Lee CG, Lee B, Lee J, Lee M.

Brain Dev. 2014 Jul 29. pii: S0387-7604(14)00182-X. doi: 10.1016/j.braindev.2014.07.005. [Epub ahead of print]

PMID:
25085837
[PubMed - as supplied by publisher]
8.

Audiological evidence of therapeutic effect of steroid treatment in neuromyelitis optica with hearing loss.

Takanashi Y, Misu T, Oda K, Miyazaki H, Yahata I, Hidaka H, Fujihara K, Kawase T, Kobayashi T, Katori Y.

J Clin Neurosci. 2014 Jul 29. pii: S0967-5868(14)00310-5. doi: 10.1016/j.jocn.2014.04.019. [Epub ahead of print]

PMID:
25085730
[PubMed - as supplied by publisher]
9.

Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party.

Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D.

Mult Scler. 2014 Jul 30. pii: 1352458514541978. [Epub ahead of print]

PMID:
25078274
[PubMed - as supplied by publisher]
10.

Pain in neuromyelitis optica-prevalence, pathogenesis and therapy.

Bradl M, Kanamori Y, Nakashima I, Misu T, Fujihara K, Lassmann H, Sandkühler J.

Nat Rev Neurol. 2014 Jul 29. doi: 10.1038/nrneurol.2014.129. [Epub ahead of print]

PMID:
25072195
[PubMed - as supplied by publisher]
11.

Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.

Aubé B, Lévesque SA, Paré A, Chamma E, Kébir H, Gorina R, Lécuyer MA, Alvarez JI, De Koninck Y, Engelhardt B, Prat A, Côté D, Lacroix S.

J Immunol. 2014 Sep 1;193(5):2438-54. doi: 10.4049/jimmunol.1400401. Epub 2014 Jul 21.

PMID:
25049355
[PubMed - in process]
12.

[Quo vadis neuroimaging? The eye as window to the brain : Current options and future perspectives].

Hassenstein A.

Ophthalmologe. 2014 Jul;111(7):676-80. doi: 10.1007/s00347-014-3090-4. German.

PMID:
25028070
[PubMed - in process]
13.

Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders.

Watanabe M, Kondo T, Murakata K, Kageyama T, Shibata Y, Takahashi T, Nomura K, Matsumoto S.

J Neuroimmunol. 2014 Jun 27. pii: S0165-5728(14)00191-X. doi: 10.1016/j.jneuroim.2014.06.020. [Epub ahead of print]

PMID:
25027061
[PubMed - as supplied by publisher]
14.

[Multiple sclerosis, neuromyelitis optica and spasticity: control of specific symptoms and quality of life].

Patejdl R, Tesar S, Zettl UK.

Fortschr Neurol Psychiatr. 2014 Jul;82(7):373-85. doi: 10.1055/s-0034-1366536. Epub 2014 Jul 11. German.

PMID:
25014200
[PubMed - in process]
15.

CD19 as a molecular target in CNS autoimmunity.

Stüve O, Warnke C, Deason K, Stangel M, Kieseier BC, Hartung HP, von Büdingen HC, Centonze D, Forsthuber TG, Knappertz V.

Acta Neuropathol. 2014 Aug;128(2):177-90. doi: 10.1007/s00401-014-1313-z. Epub 2014 Jul 4.

PMID:
24993505
[PubMed - in process]
16.

Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis.

Wu L, Huang D, Yang Y, Wu W.

Eur Neurol. 2014;72(1-2):103-8. doi: 10.1159/000358218. Epub 2014 Jul 1.

PMID:
24993096
[PubMed - in process]
17.

CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.

Delgado SR, Maldonado J, Rammohan KW.

J Neurovirol. 2014 Jul 1. [Epub ahead of print]

PMID:
24981832
[PubMed - as supplied by publisher]
18.

An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab.

Sánchez Gomar I, Díaz Sánchez M, Uclés Sánchez AJ, Casado Chocán JL, Ramírez-Lorca R, Serna A, Villadiego J, Toledo-Aral JJ, Echevarría M.

BMC Neurol. 2014 Jul 1;14(1):139. doi: 10.1186/1471-2377-14-139.

PMID:
24980919
[PubMed - in process]
Free PMC Article
19.

Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.

Long Y, Zheng Y, Shan F, Chen M, Fan Y, Zhang B, Gao C, Gao Q, Yang N.

J Neuroimmunol. 2014 Aug 15;273(1-2):103-10. doi: 10.1016/j.jneuroim.2014.06.003. Epub 2014 Jun 12.

PMID:
24972850
[PubMed - in process]
20.

Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.

Sato DK, Callegaro D, Lana-Peixoto MA, Nakashima I, Fujihara K.

Arq Neuropsiquiatr. 2014 Jun;72(6):445-50.

PMID:
24964112
[PubMed - in process]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk